Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, RAPT Therapeutics, Inc. (RAPT) has a Wall Street consensus price target of $60.00, based on estimates from 15 covering analysts. With the stock currently trading at $57.98, this represents a potential upside of +3.5%. The company has a market capitalization of $7.65B.
Analyst price targets range from a low of $58.00 to a high of $70.00, representing a 20% spread in expectations. The median target of $58.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, RAPT trades at a trailing P/E of -2.3x. Analysts expect EPS to grow +17.2% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how RAPT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus price target for RAPT is $60, close to the current price of $57.98 (3.5% implied move). Based on 15 analyst estimates, the stock appears fairly valued near current levels.
RAPT has a consensus rating of "Hold" based on 15 Wall Street analysts. The rating breakdown is mixed, with 11 Hold ratings making up the largest segment. The consensus 12-month price target of $60 implies 3.5% upside from current levels.
RAPT's current price is $57.98 with a consensus target of $60 (3.5% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $70 for RAPT, while the most conservative target is $58. The consensus of $60 represents the median expectation. These targets typically reflect 12-month expectations.
RAPT is well covered by analysts, with 15 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 11 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month RAPT stock forecast based on 15 Wall Street analysts shows a consensus price target of $60, with estimates ranging from $58 (bear case) to $70 (bull case). The median consensus rating is "Hold".
RAPT appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $60 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
RAPT analyst price targets range from $58 to $70, a 20% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $60 consensus represents the middle ground.